Brilliant Violet 605™ anti-human CD11b

Antibodies Single
Sony
ICRF44
Flow Cytometry
Mouse IgG1, κ
Human
2106655
$220.00

Description

CD11b is a 165-170 kD type I transmembrane glycoprotein also known as αM integrin, Mac-1, CR3, and C3biR. CD11b non-covalently associates with integrin β2 (CD18) and is expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b/CD18 is critical for the transendothelial migration of monocytes and neutrophils. It is also involved in granulocyte adhesion, phagocytosis, and neutrophil activation. CD11b/CD18 interacts with ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4, CD14, CD23, heparin, iC3b, fibrinogen, and factor X.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤5 microL per million cells or 5 microL per 100 microL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

References

1. Knapp W. 1989. Leucocyte Typing IV. Oxford University Press New York.
2. Barclay N, et al. 1997. The Leucocyte Antigen Facts Book. Academic Press Inc. San Diego.
3. Rezzonico R, et al. 2001. Blood 97:2932. (Stim)
4. Marsik C, et al. 2003. Shock 20:493. (FC)
5. David A, et al. 2003. J. Leukoc. Biol. 74:551. (IF)
6. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
7. Thurlow LR, et al. 2010. Infect. Immun. 128:1128. (FC) PubMed
8. Jadhav S, et al. 2001. J. Immunol. 167:5986. (Block)
9. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
10. Sestak K, et al. 2007. Vet. Immunol. Immunopathol. 119:21. (FC)
11. Wen T, et al. 2014. J Immunol. 192:5481. (FC) PubMed
12. Sprong T, et al. 2003. Blood 102:3702. (Block)
13. Cash JL, et al. 2013. EMBO Rep. 14:999. (FC) PubMed
14. Larsson K, et al. 2015. PNAS. PubMed